These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus. Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A Molecules; 2020 May; 25(11):. PubMed ID: 32485894 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations. Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993 [TBL] [Abstract][Full Text] [Related]
5. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses. Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955 [TBL] [Abstract][Full Text] [Related]
6. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
7. Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design. Bzówka M; Mitusińska K; Raczyńska A; Samol A; Tuszyński JA; Góra A Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353978 [TBL] [Abstract][Full Text] [Related]
8. Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (M Abu-Melha S; Edrees MM; Riyadh SM; Abdelaziz MR; Elfiky AA; Gomha SM Molecules; 2020 Oct; 25(19):. PubMed ID: 33036293 [TBL] [Abstract][Full Text] [Related]
9. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Dai W; Zhang B; Jiang XM; Su H; Li J; Zhao Y; Xie X; Jin Z; Peng J; Liu F; Li C; Li Y; Bai F; Wang H; Cheng X; Cen X; Hu S; Yang X; Wang J; Liu X; Xiao G; Jiang H; Rao Z; Zhang LK; Xu Y; Yang H; Liu H Science; 2020 Jun; 368(6497):1331-1335. PubMed ID: 32321856 [TBL] [Abstract][Full Text] [Related]
10. Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an Ferraz WR; Gomes RA; S Novaes AL; Goulart Trossini GH Future Med Chem; 2020 Oct; 12(20):1815-1828. PubMed ID: 32787684 [No Abstract] [Full Text] [Related]
11. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487 [TBL] [Abstract][Full Text] [Related]
12. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease. Huynh T; Wang H; Luan B Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777 [TBL] [Abstract][Full Text] [Related]
13. Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach. Murugan NA; Kumar S; Jeyakanthan J; Srivastava V Sci Rep; 2020 Nov; 10(1):19125. PubMed ID: 33154404 [TBL] [Abstract][Full Text] [Related]
14. Biochemical screening for SARS-CoV-2 main protease inhibitors. Coelho C; Gallo G; Campos CB; Hardy L; Würtele M PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015 [TBL] [Abstract][Full Text] [Related]
15. Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Gutierrez-Villagomez JM; Campos-García T; Molina-Torres J; López MG; Vázquez-Martínez J J Phys Chem Lett; 2020 Oct; 11(19):8008-8016. PubMed ID: 32840378 [TBL] [Abstract][Full Text] [Related]
16. Combining fragment docking with graph theory to improve ligand docking for homology model structures. Sarfaraz S; Muneer I; Liu H J Comput Aided Mol Des; 2020 Dec; 34(12):1237-1259. PubMed ID: 33034007 [TBL] [Abstract][Full Text] [Related]
17. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783 [TBL] [Abstract][Full Text] [Related]
18. Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors. Achutha AS; Pushpa VL; Suchitra S J Proteome Res; 2020 Nov; 19(11):4706-4717. PubMed ID: 32960061 [TBL] [Abstract][Full Text] [Related]